YAP1 and acute lymphoblastic leukemia: Furthermore, they identified LATS1—large tumour suppressor kinase—as a potential inhibitor of YAP1 phosphorylation, suggesting that targeting this pathway with verteporfin may improve the prognosis of B–ALL patients [182].